Sign in if you already have an account.
  
donate.gif

Breast Help
Resource Guide


Click here for a map and listing of breast health resources across the South Plains

RACE FOR THE CURE
SAVE THE DATE -
October 5th, 2013
Register Today!


Affiliate News

HB 438 Signed by the Governor
Thanks to the partnership between Texas Cancer Organizations, the Texas House Bill 438 for Oral Chemotherapy passed in the both the House and the Senate! This bill will require insurance companies to cover oral chemotherapy at the same level as intravenous chemotherapy. Thanks to everyone who supported this effort!.
More

State Lobby Day
Breast cancer survivors and advocates from across Texas traveled to Austin to stress to policymakers the importance of programs that help detect breast cancer early.
More

National Lobby Day
Local breast cancer survivors and activists representing the Lubbock Area Affiliate traveled to the nation’s capital April 14, joining hundreds of breast cancer activists from across the country.
More

more
Affiliate Monthly
Your Dollars at Work

Komen Lubbock is proud to announce the 2013-2014 Community Based Grant Recipients totaling $190,782 to support local breast health education

more
Take Charge of Your Health

Because a picture can be worth a thousand words, there are now 11 short videos on different procedures throughout the Understanding Breast Cancer section of komen.org. For example, you can now learn even more about needle biopsies, surgery options or lymphedema by watching these videos. Check them out to “see” and learn!

more
National Spotlight

Is ductal carcinoma in situ (DCIS) breast cancer?
Ductal carcinoma in situ (DCIS) is breast cancer, but it is non-invasive. About 55,000 new cases of DCIS are expected to be diagnosed among women in the U.S. in 2013. Learn more now.

Life after breast cancer booklet

How Komen's research investment has changed the breast cancer landscape
As we've come to understand more about the biology of breast cancer, Komen's research agenda has changed tremendously over the past 10-15 years. Read more about Komen's research investment.

Researchers conducting clinical trials
more